Brain imaging of nicotinic receptors in Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2010, Pages

  Hashimoto, Kenji ^a   Wu, Jin ^a   Ishikawa, Masatomo ^a   Zhang, Jichun ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; CARBON 11; CHIBA 1001; FLUORINE 18; IODINE 123; ION CHANNEL; NICOTINE; NICOTINIC RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN REGION; CHANNEL GATING; CHEMICAL STRUCTURE; COGNITION; HUMAN; LONG TERM POTENTIATION; MOUSE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DENSITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENIC MOUSE;

EID: 79952146830     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2010/548913     Document Type: Review

References (116)

1. Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O., Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported Journal of the American Medical Association 1989 262 18 2551 2556
2. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H. M., Forecasting the global burden of Alzheimer' (Pubitemid 46825511)
3. Octave J. N., The amyloid peptide and its precursor in Alzheimer's disease Reviews in the Neurosciences 1995 6 4 287 316
4. Grober E., Hall C. B., Lipton R. B., Zonderman A. B., Resnick S. M., Kawas C., Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease Journal of the International Neuropsychological Society 2008 14 2 266 278 (Pubitemid 351280005)
5. van Duijn C. M., Hofman A., Relation between nicotine intake and Alzheimer's disease British Medical Journal 1991 302 6791 1491 1494
6. Graves A. B., van Duijn C. M., Chandra V., Fratiglioni L., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A., Rocca W. A., Shalat S. L., Soininen H., Hofman A., Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies International Journal of Epidemiology 1991 20 supplement 2 S48 S57
7. Rusted J. M., Trawley S., Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task Neuropsychopharmacology 2006 31 7 1545 1549
8. Swan G. E., Lessov-Schlaggar C. N., The effects of tobacco smoke and nicotine on cognition and the brain Neuropsychology Review 2007 17 3 259 273 (Pubitemid 47498178)
9. Peters R., Poulter R., Warner J., Beckett N., Burch L., Bulpitt C., Smoking, dementia and cognitive decline in the elderly, a systematic review BMC Geriatrics 2008 8, article 36
10. Cataldo J. K., Prochaska J. J., Glantz S. A., Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation Journal of Alzheimer's Disease 2010 19 2 465 480
11. Cataldo J. K., Glantz S. A., Smoking cessation and Alzheimer's disease: facts, fallacies and promise Expert Review of Neurotherapeutics 2010 10 5 629 631
12. Gotti C., Zoli M., Clementi F., Brain nicotinic acetylcholine receptors: native subtypes and their relevance Trends in Pharmacological Sciences 2006 27 9 482 491 (Pubitemid 44251225)
13. Paterson D., Nordberg A., Neuronal nicotinic receptors in the human brain Progress in Neurobiology 2000 61 1 75 111 (Pubitemid 30100404)
14. Dani J. A., Bertrand D., Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system Annual Review of Pharmacology and Toxicology 2007 47 699 729
15. Guan Z. Z., Zhang X., Ravid R., Nordberg A., Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease Journal of Neurochemistry 2000 74 1 237 243 (Pubitemid 30012774)
16. Perez X. A., Bordia T., McIntosh J. M., Quik M., 6 2 and 4 2 nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease Molecular Pharmacology 2010 78 5 971 980
17. Perry E. K., Morris C. M., Court J. A., Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology Neuroscience 1995 64 2 385 395
18. Hellstrm-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A., Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain Molecular Brain Research 1999 66 1-2 94 103 (Pubitemid 29148337)
19. Burghaus L., Schtz U., Krempel U., De Vos R. A. I., Jansen Steur E. N. H., Wevers A., Lindstrom J., Schrder H., Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients Molecular Brain Research 2000 76 2 385 388 (Pubitemid 30179776)
20. Yankner B. A., Duffy L. K., Kirschner D. A., Neurotrophic and neurotoxic effects of amyloid protein: reversal by tachykinin neuropeptides Science 1990 250 4978 279 282
21. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., Yankner B. A., An in vivo model for the neurodegenerative effects of amyloid and protection by substance P Proceedings of the National Academy of Sciences of the United States of America 1991 88 16 7247 7251 (Pubitemid 21915127)
22. Kihara T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T., Akaike A., Stimulation of 4 2 nicotinic acetylcholine receptors inhibits -amyloid toxicity Brain Research 1998 792 2 331 334 (Pubitemid 28267549)
23. Fu W., Jhamandas J. H., -amyloid peptide activates non- 7 nicotinic acetylcholine receptors in rat basal forebrain neurons Journal of Neurophysiology 2003 90 5 3130 3136 (Pubitemid 37430010)
24. Wu M. N., He Y. X., Guo F., Qi J. S., 4 2 nicotinic acetylcholine receptors are required for the amyloid protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo Brain Research Bulletin 2008 77 2-3 84 90
25. Newhouse P. A., Potter A., Singh A., Effects of nicotinic stimulation on cognitive performance Current Opinion in Pharmacology 2004 4 1 36 46 (Pubitemid 38145836)
26. Loughead J., Ray R., Wileyto E. P., Ruparel K., Sanborn P., Siegel S., Gur R. C., Lerman C., Effects of the 4 2 partial agonist varenicline on brain activity and working memory in abstinent smokers Biological Psychiatry 2010 67 8 715 721
27. Flynn D. D., Mash D. C., Characterization of L-[ 3 H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal Journal of Neurochemistry 1986 47 6 1948 1954 (Pubitemid 17191516)
28. Whitehouse P. J., Martino A. M., Antuono P. G., Nicotinic acetylcholine binding sites in Alzheimer's disease Brain Research 1986 371 1 146 151 (Pubitemid 16066186)
29. Whitehouse P. J., Martino A. M., Wagster M. V., Price D. L., Mayeux R., Atack J. R., Kellar K. J., Reductions in [ 3 H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study Neurology 1988 38 5 720 723
30. Warpman U., Nordberg A., Epibatidine and ABT 418 reveal selective losses of 4 2 nicotinic receptors in Alzheimer brains NeuroReport 1995 6 17 2419 2423 (Pubitemid 26010081)
31. Marutle A., Warpman U., Bogdanovic N., Lannfelt L., Nordberg A., Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation Journal of Neurochemistry 1999 72 3 1161 1169 (Pubitemid 29085032)
32. Wevers A., Burghaus L., Moser N., Witter B., Steinlein O. K., Schtz U., Achnitz B., Krempel U., Nowacki S., Pilz K., Stoodt J., Lindstrom J., De Vos R. A. I., Jansen Steur E. N. H., Schrder H., Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches Behavioural Brain Research 2000 113 1-2 207 215 (Pubitemid 30645558)
33. Gallezot J. D., Bottlaender M., Grgoire M. C., Roumenov D., Deverre J. R., Coulon C., Ottaviani M., Doll F., Syrota A., Valette H., in vivo imaging of human cerebral nicotinic acetylcholine receptors with 2- 18 F-fluoro-A-85380 and PET Journal of Nuclear Medicine 2005 46 2 240 247 (Pubitemid 43073430)
34. Brody A. L., Mandelkern M. A., London E. D., Olmstead R. E., Farahi J., Scheibal D., Jou J., Allen V., Tiongson E., Chefer S. I., Koren A. O., Mukhin A. G., Cigarette smoking saturates brain 4 2 nicotinic acetylcholine receptors Archives of General Psychiatry 2006 63 8 907 915
35. Kadir A., Almkvist O., Wall A., Lngstrm B., Nordberg A., PET imaging of cortical C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease Psychopharmacology 2006 188 4 509 520 (Pubitemid 46758966)
36. Maziere M., Comar D., Marazano C., Berger G., Nicotine 11 C: synthesis and distribution kinetics in animals European Journal of Nuclear Medicine 1976 1 4 255 258 (Pubitemid 8001699)
37. Halldin C., Nagren K., Swahn C. G., Langstrom B., Nyback H., (S)- and (R)-[ 11 C]nicotine and the metabolite (R/S)-[ 11 C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET International Journal of Radiation Applications and Instrumentation B 1992 19 8 871 880
38. Nyback H., Nordberg A., Langstrom B., Halldin C., Hartvig P., Ahlin A., Swahn C. G., Sedvall G., Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography Progress in Brain Research 1989 79 313 319 (Pubitemid 20047994)
39. Nordberg A., Nilsson-Hakansson L., Adem A., Hardy J., Alufuzoff I., Lai Z., Herrera-Marschitz M., Winblad B., The role of nicotinic receptors in the pathophysiology of Alzheimer's disease Progress in Brain Research 1989 79 353 362 (Pubitemid 20047999)
40. Nordberg A., Lundqvist H., Hartvig P., Lilja A., Langstrom B., Kinetic analysis of regional (S)(-) 11 C-nicotine binding in normal and Alzheimer brains in vivo assessment using positron emission tomography Alzheimer Disease and Associated Disorders 1995 9 1 21 27
41. Kadir A., Darreh-Shori T., Almkvist O., Wall A., Grut M., Strandberg B., Ringheim A., Eriksson B., Blomquist G., Lngstrm B., Nordberg A., PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD Neurobiology of Aging 2008 29 8 1204 1217 (Pubitemid 351822413)
42. Nordberg A., Lundqvist H., Hartvig P., Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment Dementia and Geriatric Cognitive Disorders 1997 8 2 78 84 (Pubitemid 27173499)
43. Grunwald F., Biersack H. J., Kuschinsky W., Sorger D., Kampfer I., Knapp W. H., Nicotine receptor mapping European Journal of Nuclear Medicine 1996 23 8 1012 1014
44. Sullivan J. P., Donnelly-Roberts D., Briggs C. A., Anderson D. J., Gopalakrishnan M., Piattoni-Kaplan M., Campbell J. E., McKenna D. G., Molinari E., Hettinger A. M., Garvey D. S., Wasicak J. T., Holladay M. W., Williams M., Arneric S. P., A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity 4 2 nicotinic acetylcholine receptor ligand Neuropharmacology 1996 35 6 725 734 (Pubitemid 26308549)
45. Rueter L. E., Meyer M. D., Decker M. W., Spinal mechanisms underlying A-85380-induced effects on acute thermal pain Brain Research 2000 872 1-2 93 101 (Pubitemid 30618891)
46. Buckley M. J., Surowy C., Meyer M., Curzon P., Mechanism of action of A-85380 in an animal model of depression Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004 28 4 723 730 (Pubitemid 38987398)
47. Rueter L. E., Donnelly-Roberts D. L., Curzon P., Briggs C. A., Anderson D. J., Bitner R. S., A-85380: a pharmacological probe for the preclinical and clinical investigation of the neuronal nicotinic acetylcholine receptor CNS Drug Reviews 2006 12 2 100 112 (Pubitemid 44313714)
48. Mukhin A. G., Gndisch D., Horti A. G., Koren A. O., Tamagnan G., Kimes A. S., Chambers J., Vaupel D. B., King S. L., Picciotto M. R., Innis R. B., London E. D., 5-iodo-a-85380, an 4 2 subtype-selective ligand for nicotinic acetylcholine receptors Molecular Pharmacology 2000 57 3 642 649 (Pubitemid 30140897)
49. Chefer S. I., London E. D., Koren A. O., Pavlova O. A., Kurian V., Kimes A. S., Horti A. G., Mukhin A. G., Graphical analysis of 2-[ 18 F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain Synapse 2003 48 1 25 34 (Pubitemid 36249888)
50. Kimes A. S., Horti A. G., London E. D., Chefer S. I., Contoreggi C., Ernst M., Friello P., Koren A. O., Kurian V., Matochik J. A., Pavlova O., Vaupel D. B., Mukhin A. G., 2-[ 18 F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans FASEB Journal 2003 17 10 1331 1333
51. Ellis J. R., Villemagne V. L., Nathan P. J., Mulligan R. S., Gong S. J., Chan J. G., Sachinidis J., O'Keefe G. J., Pathmaraj K., Wesnes K. A., Savage G., Rowe C. C., Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[ 18 F]fluoro-A-85380 PET study Neurobiology of Learning and Memory 2008 90 2 404 412
52. Fujita M., Ichise M., van Dyck C. H., Zoghbi S. S., Tamagnan G., Mukhin A. G., Bozkurt A., Seneca N., Tipre D., DeNucci C. C., Iida H., Vaupel D. B., Horti A. G., Koren A. O., Kimes A. S., London E. D., Seibyl J. P., Baldwin R. M., Innis R. B., Quantification of nicotinic acetylcholine receptors in human brain using [ 123 I]5-I-A-85380 SPET European Journal of Nuclear Medicine and Molecular Imaging 2003 30 12 1620 1629 (Pubitemid 38017429)
53. Mitsis E. M., Cosgrove K. P., Staley J. K., Bois F., Frohlich E. B., Tamagnan G. D., Estok K. M., Seibyl J. P., van Dyck C. H., Age-related decline in nicotinic receptor availability with [ 123 I]5-IA-85380 SPECT Neurobiology of Aging 2009 30 9 1490 1497
54. Cosgrove K. P., Batis J., Bois F., Maciejewski P. K., Esterlis I., Kloczynski T., Stiklus S., Krishnan-Sarin S., O'Malley S., Perry E., Tamagnan G., Seibyl J. P., Staley J. K., 2-nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking Archives of General Psychiatry 2009 66 6 666 676
55. Brody A. L., Mandelkern M. A., Costello M. R., Abrams A. L., Scheibal D., Farahi J., London E. D., Olmstead R. E., Rose J. E., Mukhin A. G., Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette International Journal of Neuropsychopharmacology 2009 12 3 305 316
56. Sabri O., Kendziorra K., Wolf H., Gertz H. J., Brust P., Acetylcholine receptors in dementia and mild cognitive impairment European Journal of Nuclear Medicine and Molecular Imaging 2008 35 1 S30 S45
57. Kendziorra K., Wolf H., Meyer P. M., Barthel H., Hesse S., Becker G. A., Luthardt J., Schildan A., Patt M., Sorger D., Seese A., Gertz H.-J., Sabri O., Decreased cerebral 4 2 nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. In press
58. Mitsis E. M., Reech K. M., Bois F., Tamagnan G. D., MacAvoy M. G., Seibyl J. P., Staleyy J. K., Van Dyck C. H., 123 I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment Journal of Nuclear Medicine 2009 50 9 1455 1463
59. O'Brien J. T., Colloby S. J., Pakrasi S., Perry E. K., Pimlott S. L., Wyper D. J., McKeith I. G., Williams E. D., 4 2 nicotinic receptor status in Alzheimer's disease using I-5IA-85380 single-photon-emission computed tomography Journal of Neurology, Neurosurgery and Psychiatry 2007 78 4 356 361 (Pubitemid 46580540)
60. Colloby S. J., Perry E. K., Pakrasi S., Pimlott S. L., Wyper D. J., McKeith I. G., Williams E. D., O'Brien J. T., Nicotinic 123 I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in alzheimer's disease and dementia with lewy Bodies American Journal of Geriatric Psychiatry 2010 18 1 86 90
61. Ellis J. R., Nathan P. J., Villemagne V. L., Mulligan R. S., Saunder T., Young K., Smith C. L., Welch J., Woodward M., Wesnes K. A., Savage G., Rowe C. C., Galantamine-induced improvements in cognitive function are not related to alterations in 4 2 nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[ 18 F]Fluoro-A- 85380 PET Psychopharmacology 2009 202 13 79 91
62. Clarke P. B. S., The fall and rise of neuronal -bungarotoxin binding proteins Trends in Pharmacological Sciences 1992 13 11 407 413
63. Wang H. Y., Lee D. H. S., D'Andrea M. R., Peterson P. A., Shank R. P., Reitz A. B., -Amyloid(142) binds to 7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology Journal of Biological Chemistry 2000 275 8 5626 5632 (Pubitemid 30115201)
64. Wang H. Y., Lee D. H. S., Davis C. B., Shank R. P., Amyloid peptide A (142) binds selectively and with picomolar affinity to 7 nicotinic acetylcholine receptors Journal of Neurochemistry 2000 75 3 1155 1161 (Pubitemid 30660505)
65. D'Andrea M. R., Nagele R. G., Wang H. Y., Peterson P. A., Lee D. H. S., Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease Histopathology 2001 38 2 120 134 (Pubitemid 32193626)
66. Dziewczapolski G., Glogowski C. M., Masliah E., Heinemann S. F., Deletion of the 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease Journal of Neuroscience 2009 29 27 8805 8815
67. Bencherif M., Lippiello P. M., 7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology? Medical Hypotheses 2010 74 2 281 285
68. Bencherif M., Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance Acta Pharmacologica Sinica 2009 30 6 702 714
69. Eddins D., Klein R. C., Yakel J. L., Levin E. D., Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment Brain Research Bulletin 2009 79 2 111 115
70. Bitner R. S., Nikkel A. L., Markosyan S., Otte S., Puttfarcken P., Gopalakrishnan M., Selective 7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3 and decreases tau phosphorylation in vivo Brain Research 2009 1265 C 65 74
71. Faras G. G., Valls A. S., Colombres M., Godoy J. A., Toledo E. M., Lukas R. J., Barrantes F. J., Inestrosa N. C., Wnt-7a induces presynaptic colocalization of 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons Journal of Neuroscience 2007 27 20 5313 5325 (Pubitemid 46790156)
72. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A and synaptic dysfunction Neuron 2003 39 3 409 421 (Pubitemid 36937044)
73. Oddo S., Caccamo A., Green K. N., Liang K., Tran L., Chen Y., Leslie F. M., LaFerla F. M., Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 3046 3051 (Pubitemid 40299913)
74. Billings L. M., Oddo S., Green K. N., McGaugh J. L., LaFerla F. M., Intraneuronal A causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice Neuron 2005 45 5 675 688 (Pubitemid 40320703)
75. Nordberg A., Hellstrm-Lindahl E., Lee M., Johnson M., Mousavi M., Hall R., Perry E., Bednar I., Court J., Chronic nicotine treatment reduces -amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) Journal of Neurochemistry 2002 81 3 655 658 (Pubitemid 34809344)
76. Unger C., Svedberg M. M., Yu W. F., Hedberg M. M., Nordberg A., Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice Journal of Pharmacology and Experimental Therapeutics 2006 317 1 30 36
77. Brendza R. P., Bacskai B. J., Cirrito J. R., Simmons K. A., Skoch J. M., Klunk W. E., Mathis C. A., Bales K. R., Paul S. M., Hyman B. T., Holtzman D. M., Anti-A antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice Journal of Clinical Investigation 2005 115 2 428 433 (Pubitemid 40385484)
78. Orr-Urtreger A., Goldner F. M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J. A., Patrick J. W., Beaudet A. L., Mice deficient in the 7 neuronal nicotinic acetylcholine receptor lack -bungarotoxin binding sites and hippocampal fast nicotinic currents Journal of Neuroscience 1997 17 23 9165 9171 (Pubitemid 27498444)
79. Paylor R., Nguyen M., Crawley J. N., Patrick J., Beaudet A., Orr-Urtreger A., 7 nicotinic receptor subunits are not necessary for hippocampal- dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice Learning and Memory 1998 5 4-5 302 316 (Pubitemid 29115261)
80. Hoyle E., Genn R. F., Fernandes C., Stolerman I. P., Impaired performance of 7 nicotinic receptor knockout mice in the five-choice serial reaction time task Psychopharmacology 2006 189 2 211 223 (Pubitemid 44691543)
81. Young J. W., Crawford N., Kelly J. S., Kerr L. E., Marston H. M., Spratt C., Finlayson K., Sharkey J., Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice European Neuropsychopharmacology 2007 17 2 145 155 (Pubitemid 44802833)
82. Fernandes C., Hoyle E., Dempster E., Schalkwyk L. C., Collier D. A., Performance deficit of 7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory Genes, Brain and Behavior 2006 5 6 433 440 (Pubitemid 44199563)
83. Keller J. J., Keller A. B., Bowers B. J., Wehner J. M., Performance of 7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task Behavioural Brain Research 2005 162 1 143 152 (Pubitemid 40726288)
84. Hernandez C. M., Kayed R., Zheng H., Sweatt J. D., Dineley K. T., Loss of 7 nicotinic receptors enhances -amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease Journal of Neuroscience 2010 30 7 2442 2453
85. Hashimoto K., Fujita Y., Ishima T., Hagiwara H., Iyo M., Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of 7 nicotinic receptors European Journal of Pharmacology 2006 553 13 191 195 (Pubitemid 44779614)
86. Boess F. G., de Vry J., Erb C., Flessner T., Hendrix M., Luithle J., Methfessel C., Riedl B., Schnizler K., Van Der Staay F.-J., Van Kampen M., Wiese W. B., Koenig G., The novel 7 nicotinic acetylcholine receptor agonist N-[(3 R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2- carboxamide improves working and recognition memory in rodents Journal of Pharmacology and Experimental Therapeutics 2007 321 2 716 725 (Pubitemid 46624485)
87. van Kampen M., Selbach K., Schneider R., Schiegel E., Boess F., Schreiber R., AR-R 17779 improves social recognition in rats by activation of nicotinic 7 receptors Psychopharmacology 2004 172 4 375 383 (Pubitemid 38650972)
88. Pichat P., Bergis O. E., Terranova J. P., Urani A., Duarte C., Santucci V., Gueudet C., Voltz C., Steinberg R., Stemmelin J., Oury-Donat F., Avenet P., Griebel G., Scatton B., SSR180711, a novel selective 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia Neuropsychopharmacology 2007 32 1 17 34 (Pubitemid 44967781)
89. Hashimoto K., Nishiyama S., Ohba H., Matsuo M., Kobashi T., Takahagi M., Iyo M., Kitashoji T., Tsukada H., [ 11 C]CHIBA-1001 as a novel PET ligand for 7 nicotinic receptors in the brain: a PET study in conscious monkeys PLoS ONE 2008 3 9, article e3231
90. Tietje K. R., Anderson D. J., Bitner R. S., Blomme E. A., Brackemeyer P. J., Briggs C. A., Browman K. E., Bury D., Curzon P., Drescher K. U., Frost J. M., Fryer R. M., Fox G. B., Gronlien J. H., Hkerud M., Gubbins E. J., Halm S., Harris R., Helfrich R. J., Kohlhaas K. L., Law D., Malysz J., Marsh K. C., Martin R. L., Meyer M. D., Molesky A. L., Nikkel A. L., Otte S., Pan L., Puttfarcken P. S., Radek R. J., Robb H. M., Spies E., Thorin-Hagene K., Waring J. F., Ween H., Xu H., Gopalakrishnan M., Bunnelle W. H., Preclinical characterization of A-582941: a novel 7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties CNS Neuroscience and Therapeutics 2008 14 1 65 82
91. Roncarati R., Scali C., Comery T. A., Grauer S. M., Aschmi S., Bothmann H., Jow B., Kowal D., Gianfriddo M., Kelley C., Zanelli U., Ghiron C., Haydar S., Dunlop J., Terstappen G. C., Procognitive and neuroprotective activity of a novel 7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders Journal of Pharmacology and Experimental Therapeutics 2009 329 2 459 468
92. Briggs C. A., Anderson D. J., Brioni J. D., Buccafusco J. J., Buckley M. J., Campbell J. E., Decker M. W., Donnelly-Roberts D., Elliott R. L., Gopalakrishnan M., Holladay M. W., Hui YU. H., Jackson W. J., Kim D. J. B., Marsh K. C., O'Neill A., Prendergast M. A., Ryther K. B., Sullivan J. P., Arneric S. P., Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo Pharmacology Biochemistry and Behavior 1997 57 1-2 231 241 (Pubitemid 27261416)
93. Buccafusco J. J., Terry A. V. Jr., Decker M. W., Gopalakrishnan M., Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys Biochemical Pharmacology 2007 74 8 1202 1211 (Pubitemid 47417930)
94. Liu Q., Zhang J., Zhu H., Qin C., Chen Q., Zhao B., Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model FASEB Journal 2007 21 1 61 73 (Pubitemid 46052545)
95. Chen L., Wang H., Zhang Z., Li Z., He D., Sokabe M., Chen L., DMXB (GTS-21) ameliorates the cognitive deficits in beta amyloid 25-35 -injected mice through preventing the dysfunction of 7 nicotinic receptor Journal of Neuroscience Research 2010 88 8 1784 1794
96. Wang H. Y., Bakshi K., Shen C., Frankfurt M., Trocm-Thibierge C., Morain P., S 24795 limits -amyloid- 7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies Biological Psychiatry 2010 67 6 522 530
97. Hashimoto K., Iyo M., Amyloid cascade hypothesis of Alzheimer's disease and 7 nicotinic receptor Nihon Shinkei Seishin Yakurigaku Zasshi 2002 22 2 9 53
98. Toyohara J., Hashimoto K., 7 nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer's disease Open Medicinal Chemistry Journal 2010 4 37 56
99. Nordberg A., Human nicotinic receptorstheir role in aging and dementia Neurochemistry International 1994 25 1 93 97 (Pubitemid 24229672)
100. Nordberg A., Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications Biological Psychiatry 2001 49 3 200 210 (Pubitemid 32178429)
101. Whitehouse P. J., Kalaria R. N., Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications Alzheimer Disease and Associated Disorders 1995 9 supplement 2 3 5
102. Martin-Ruiz C. M., Court J. A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R. H., Perry E. K., 4 but not 3 and 7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease Journal of Neurochemistry 1999 73 4 1635 1640 (Pubitemid 29440166)
103. Davies P., Feisullin S., Postmortem stability of -bungarotoxin binding sites in mouse and human brain Brain Research 1981 216 2 449 454 (Pubitemid 11082231)
104. Engidawork E., Gulesserian T., Balic N., Cairns N., Lubec G., Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease Journal of Neural Transmission, Supplement 2001 61 211 222 (Pubitemid 38085084)
105. Falk L., Nordberg A., Seiger A., Kjaeldgaard A., Hellstrm-Lindahl E., Higher expression of 7 nicotinic acetylcholine receptors in human fetal compared to adult brain Developmental Brain Research 2003 142 2 151 160 (Pubitemid 36593158)
106. Marutle A., Zhang X., Court J., Piggott M., Johnson M., Perry R., Perry E., Nordberg A., Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia Journal of Chemical Neuroanatomy 2001 22 1-2 115 126 (Pubitemid 32695514)
107. Court J. A., Perry E. K., Spurden D., Griffiths M., Kerwin J. M., Morris C. M., Johnson M., Oakley A. E., Birdsall N. J. M., Clementi F., Perry R. H., The role of the cholinergic system in the development of the human cerebellum Developmental Brain Research 1995 90 1-2 159 167
108. Court J., Martin-Ruiz C., Piggott M., Spurden D., Griffiths M., Perry E., Nicotinic receptor abnormalities in Alzheimer's disease Biological Psychiatry 2001 49 3 175 184 (Pubitemid 32178426)
109. James R. W., Bersinger N. A., Schwendimann B., Fulpius B. W., Characterization of iodinated derivatives of -bungarotoxin Hoppe-Seyler's Zeitschrift fur Physiologische Chemie 1980 361 10 1517 1524
110. Davies A. R. L., Hardick D. J., Blagbrough I. S., Potter B. V. L., Wolstenholme A. J., Wonnacott S., Characterisation of the binding of [ 3 H]methyllycaconitine: a new radioligand for labelling 7-type neuronal nicotinic acetylcholine receptors Neuropharmacology 1999 38 5 679 690 (Pubitemid 29150322)
111. Navarro H. A., Zhong D., Abraham P., Xu H., Carroll F. I., Synthesis and pharmacological characterization of [ 125 I]iodomethyllycaconitine ([ 125 I]iodo-MLA). A new ligand for the (7) nicotinic acetylcholine receptor Journal of Medicinal Chemistry 2000 43 2 142 145 (Pubitemid 30078145)
112. Toyohara J., Wu J., Hashimoto K., Recent development of radioligands for imaging 7 nicotinic acetylcholine receptors in the brain Current Topics in Medicinal Chemistry 2010 10 15 1544 1557
113. Tanibuchi Y., Wu J., Toyohara J., Fujita Y., Iyo M., Hashimoto K., Characterization of [ 3 H]CHIBA-1001 binding to 7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human Brain Research 2010 1348 C 200 208
114. Toyohara J., Sakata M., Wu J., Ishikawa M., Oda K., Ishii K., Iyo M., Hashimoto K., Ishiwata K., Preclinical and the first clinical studies on [ 11 C]CHIBA-1001 for mapping 7 nicotinic receptors by positron emission tomography Annals of Nuclear Medicine 2009 23 3 301 309
115. Sakata M., Wu J., Toyohara J., Oda K., Ishikawa M., Ishii K., Hashimoto K., Ishiwata K., Biodistribution and radiation dosimetry of the 7 nicotinic acetylcholine receptor ligand [ 11 C]CHIBA-1001 in humans. Nuclear Medicine and Biology. In press
116. 125MI] CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes," Brain Research, vol. 1360, no. C, pp. 130-137, 2010.